Background illustration for clinical trials search

Paid Clinical Trials Georgia

Discover 1,881 paid clinical trials in Georgia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

for
Sickle Cell Disease, Hematopoetic Stem Cell Transplant,
Location: Atlanta GA
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 12 - 45

Code: NCT07252050

Phase1, Phase2, Recruiting
Active & Responsive

A Gaucher Disease Gene Therapy Trial With FLT201

for
Gaucher Disease Type 1
Location: New York NY, Montreal, Philadelphia PA, Fairfax VA,
Sponsor: Spur Therapeutics

Sex: All

Age: 18+

Code: NCT07223944

Phase3, Recruiting
Active & Responsive

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

for
Myotonic Dystrophy Type 1 (DM1), DM1, Myotonic Dystrophy,
Location: Richmond VA, Atlanta GA, Hillsborough NC,
Sponsor: Dyne Therapeutics

Sex: All

Age: 16+

Code: NCT07486934

Phase3, Recruiting
Active & Responsive

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

for
Solid Tumor, Non-Small-Cell Lung Cancer,
Location: New York NY, Hackensack NJ, Fairfax VA, Buffalo NY,
Sponsor: Astellas Pharma Inc

Sex: All

Age: 18+

Code: NCT07094204

Phase1, Recruiting
Active & Responsive

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

for
Kidney Disease
Location: East Providence RI, Philadelphia PA, Media PA,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06963827

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

for
Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Location: New York NY, Philadelphia PA, Washington D.C. DC,
Sponsor: Electra Therapeutics Inc.

Sex: All

Age: 6+

Code: NCT05416307

Phase2, Phase3, Recruiting
Active & Responsive

A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults

for
Cervical Dystonia
Location: New York NY, Boca Raton FL, Farmington Hills MI,
Sponsor: Ipsen

Sex: All

Age: 18 - 70+

Code: NCT06937931

Phase2, Recruiting
Active & Responsive

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

for
Lung Cancer Diagnosis
Location: Hyannis MA, Stamford CT, Mullica Hill NJ,
Sponsor: Freenome Holdings Inc.

Sex: All

Age: 50+

Code: NCT06122077

Recruiting
Active & Responsive

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Boston MA, New Haven CT, New York NY, New Brunswick NJ,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT05303519

Phase3, Recruiting
Active & Responsive

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06982521

Phase3, Recruiting
Active & Responsive

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

for
Breast Neoplasms, Colorectal Neoplasms, Prostate Neoplasm,
Location: Boston MA, New York NY, Toronto, Hamilton, Tampa FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07114601

Phase1, Recruiting
Active & Responsive

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: Boston MA, Providence RI, Worcester MA, Hartford CT,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT06901531

Phase3, Recruiting
Active & Responsive

Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B

for
Hemophilia B
Location: Gainesville FL, Atlanta GA, Ann Arbor MI, Memphis TN,
Sponsor: CSL Behring

Sex: Male

Age: 11 - 17

Code: NCT07080905

Phase3, Recruiting
Active & Responsive

A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)

for
Lower Extremity Acute Limb Ischemia, LE ALI
Location: Worcester MA, New Haven CT, Lebanon NH, New York NY,
Sponsor: Penumbra Inc.

Sex: All

Age: 18+

Code: NCT06747117

Recruiting
Active & Responsive

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

for
Atopic Dermatitis
Location: Fredericton, Quebec, New York NY, Montreal,
Sponsor: Apogee Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07003425

Phase2, Recruiting
Active & Responsive

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

for
Immune Thrombocytopenic Purpura (ITP)
Location: Boston MA, Worcester MA, Philadelphia PA, Norfolk VA,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06722235

Phase3, Recruiting
Active & Responsive

A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

for
Huntington Disease
Location: Boston MA, Farmington CT, New York NY, Burlington VT,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 21 - 70

Code: NCT07326709

Phase3, Recruiting
Active & Responsive

Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma

for
Osteosarcoma Recurrent, Osteosarcoma in Children,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 1 - 30

Code: NCT07144254

Phase1, Recruiting
Active & Responsive

Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome

for
Myelodysplastic Syndromes
Location: The Bronx NY, Baltimore MD, Miami FL, Orlando FL,
Sponsor: Syntrix Biosystems, Inc.

Sex: All

Age: 18+

Code: NCT04245397

Phase1, Recruiting
Active & Responsive

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

for
Advanced Melanoma
Location: Boston MA, Lake Success NY, New York NY,
Sponsor: Immunocore Ltd

Sex: All

Age: 18+

Code: NCT05549297

Phase3, Recruiting

Popular cities in Georgia

AthensSandy SpringsAtlantaNewnanAugustaSavannah